Biotechnology at Stevenson University

A debt-to-earnings ratio of 0.51 isn't terrible for a science bachelor's degree, but here's the complication: both figures come from estimates based on peer programs nationally, so we're essentially comparing averages to averages without knowing how Stevenson's specific outcomes stack up. The estimated $47,000 first-year salary aligns precisely with the national median for biotechnology programs, while the projected $24,125 in debt sits slightly above the national median of $20,618. That suggests graduates would need roughly half a year's salary to cover their loans—manageable under federal repayment plans, though not exceptional.

Maryland's biotech corridor—particularly around Baltimore and the I-270 corridor—does offer genuine industry opportunities at companies like AstraZeneca and Emergent BioSolutions. The question is whether Stevenson's specific program successfully connects students to these employers. With only two schools in Maryland offering this degree, there's limited state-level data to assess competitive positioning. The 83% admission rate suggests accessible entry, but without actual graduate outcomes from this campus, it's impossible to know whether their curriculum and industry partnerships translate into the kinds of positions these estimates assume.

The practical takeaway: these estimates suggest a reasonable investment if your student actually lands in the biotechnology field earning close to $47,000. Before committing, verify Stevenson's placement specifics—where do their biotech graduates actually work, and what do they earn? The difference between a lab tech role at $35,000 and a research associate position at $50,000 would dramatically change this program's value.